AMPK activators (Dainippon Sumitomo)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAMPK activators (Dainippon Sumitomo)
Drug Alias NameAMP activated protein kinase activator (Dainippon Sumitomo)DNP-60502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsDiabetes Mellitus, Type 2Metabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Metabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A